North American Molecular Diagnostics Market Trends

Segmentation Analysis:

The North American Molecular Diagnostics Market is segmented by Product, Test Location, Technology, Application, Regional. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.

• Based on Product the market is segmented as, Instruments, Reagents
• Based on Test Location the market is segmented as, Point-of-Care (PoC), Self-test or Over the Counter (OTC), Central Laboratories
• Based on Technology the market is segmented as, Polymerase Chain Reaction (PCR), Multiplex PCR, Other PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification, Others
• Based on Application the market is segmented as, Oncology, Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Blood Cancer, Lung Cancer, Other Cancer, Pharmacogenomics, Infectious Diseases, Methicillin-resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Vancomycin-resistant Enterococci (VRE), Carbapenem-resistant Bacteria, Flu, Respiratory Syncytial Virus (RSV), Candida, Tuberculosis and drug-resistant TBA, Meningitis, Gastrointestinal Panel Testing, Chlamydia, Gonorrhea, HIV, Hepatitis C, Hepatitis B, Other Infectious Disease, Genetic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Other Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, Others
• Based on Regional the market is segmented as, The U.S.